AVITA Medical, Inc. (RCEL) Tops Q4 EPS by 3c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q4 EPS of ($0.21), $0.03 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $9.46 million versus the consensus estimate of $8.8 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Nvidia underperforms peers as report sparks rack delay worries
• Morgan Stanley Downgrades Seven & i Holdings Co Ltd (3382:JP) (SVNDF) to Equalweight, Earnings US May Peak F2/27
• Morgan Stanley Resumes Bath & Body Works Inc. (BBWI) at Equalweight